Intellia Therapeutics (NTLA) FCF Margin Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
11,587.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
11,587.00 |
| Dec 31, 2025 |
32,783.00 |
| Sep 30, 2025 |
41,891.00 |
| Jun 30, 2025 |
11,064.00 |
| Mar 31, 2025 |
-47,053.00 |
| Dec 31, 2024 |
-548,172.00 |
| Sep 30, 2024 |
-18,635.00 |
| Jun 30, 2024 |
-11,334.00 |
| Mar 31, 2024 |
47,200.00 |
| Dec 31, 2023 |
554,368.00 |
| Sep 30, 2023 |
-16,665.00 |
| Jun 30, 2023 |
-7,755.00 |
| Mar 31, 2023 |
-15,538.00 |
| Dec 31, 2022 |
-24,346.00 |
| Sep 30, 2022 |
2.26 Mn |
| Jun 30, 2022 |
25,827.00 |
| Mar 31, 2022 |
8,435.00 |
| Dec 31, 2021 |
14,623.00 |
| Sep 30, 2021 |
-2.30 Mn |
| Jun 30, 2021 |
-123,239.00 |
